Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib
Blood Cancer J
.
2023 May 3;13(1):65.
doi: 10.1038/s41408-023-00834-6.
Authors
Francesca Palandri
1
,
Elena M Elli
2
,
Giuseppe Auteri
3
4
,
Massimiliano Bonifacio
5
,
Giulia Benevolo
6
,
Florian H Heidel
7
,
Simona Paglia
3
,
Malgorzata M Trawinska
8
,
Costanza Bosi
9
,
Elena Rossi
10
11
,
Mario Tiribelli
12
,
Alessia Tieghi
13
,
Alessandra Iurlo
14
,
Nicola Polverelli
15
,
Giovanni Caocci
16
,
Gianni Binotto
17
,
Francesco Cavazzini
18
,
Eloise Beggiato
6
,
Daniela Cilloni
19
,
Caterina Tatarelli
20
,
Francesco Mendicino
21
,
Maurizio Miglino
22
23
,
Monica Bocchia
24
,
Monica Crugnola
25
,
Camilla Mazzoni
3
4
,
Andrea D Romagnoli
3
4
,
Giovanni Rindone
2
,
Sara Ceglie
10
,
Alessandra D'Addio
26
,
Eleonora Santoni
5
,
Daniele Cattaneo
14
,
Daniela Bartoletti
3
,
Roberto M Lemoli
22
23
,
Mauro Krampera
5
,
Antonio Cuneo
18
,
Gianpietro C Semenzato
17
,
Roberto Latagliata
27
,
Elisabetta Abruzzese
8
,
Nicola Vianelli
3
,
Michele Cavo
3
4
,
Alessandro Andriani
28
,
Valerio De Stefano
10
11
,
Giuseppe A Palumbo
29
,
Massimo Breccia
30
Affiliations
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy. francesca.palandri@unibo.it.
2
Hematology Division, San Gerardo Hospital, ASST Monza, Monza, Italy.
3
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
4
Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
5
Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
6
Hematology U, Department of Oncology, Città della Salute e della Scienza, Turin, Italy.
7
Innere Medicine C, Universitätsmedizin Greifswald, Greifswald, Germany.
8
Hematology, S.Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy.
9
Division of Hematology, AUSL di Piacenza, Piacenza, Italy.
10
Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University School of Medicine, Rome, Italy.
11
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
12
Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
13
Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
14
Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
15
Unit of Blood Diseases and Stem Cell Transplantation, ASST Spedali Civili di Brescia, Brescia, Italy.
16
Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
17
Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy.
18
Division of Hematology, University of Ferrara, Ferrara, Italy.
19
Haematology Division, Department of Clinical and Biological Sciences, Ospedale San Luigi di Orbassano, University of Turin, Orbassano, Italy.
20
Hematology, S.Andrea Hospital, Rome, Italy.
21
Unit of Hematology, Hospital of Cosenza, Cosenza, Italy.
22
IRCCS Policlinico San Martino, Genova, Italy.
23
Dipartimento di Medicina interna e Specialità mediche, Università di Genova, Genova, Italy.
24
Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
25
Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
26
Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Italy.
27
Hematology Unit, Ospedale Belcolle, Viterbo, Italy.
28
Villa Betania Hospital, Roma, Italy.
29
Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", Università degli Studi di Catania, Catania, Italy.
30
A.O.U. Policlinico Umberto I, Università degli Studi di Roma "La Sapienza", Rome, Italy.
PMID:
37137878
PMCID:
PMC10155661
DOI:
10.1038/s41408-023-00834-6
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
Myeloproliferative Disorders*
Nitriles
Pyrazoles / therapeutic use
Pyrimidines
Substances
ruxolitinib
Nitriles
Pyrimidines
Pyrazoles